Cookie Consent
Hi, this website uses essential cookies to ensure its proper operation and tracking cookies to understand how you interact with it. The latter will be set only after consent.
Read our Privacy Policy

Lakera Co-publishes Article in a Nature Journal on Testing Medical Imaging Systems

The paper that we have now published in Nature summarizes the results and derives general recommendations for the collection of test datasets in pathology and medical imaging.

Lakera Team
November 14, 2023
Hide table of contents
Show table of contents

At Lakera, we believe that AI will give rise to completely new types of medical applications. We have the potential to diagnose diseases earlier and more accurately than ever before. At the same time, companies that want to innovate safely, have to put reliability and trust at the core of their development and operations. Not such an easy task!

Before these AI technologies are put into hospitals, it is important to evaluate their predictive performance and obtain regulatory approval. This requires appropriate testing methodologies that far exceed how testing is done in other industries – an undertaking that can quickly become overwhelming for development teams.

With Lakera's products, we enable our customers to automate such testing as part of existing engineering processes and speed up regulatory approval.

We want to help more companies innovate safely with AI in the medical domain. This is why, earlier this year, we joined a committee of leading medical researchers and AI developers to discuss key aspects and conduct extensive literature reviews on test datasets in one of the leading and most challenging medical applications: pathology.

The paper that we have now published summarizes the results and derives general recommendations for the collection of test datasets in pathology and medical imaging.

We address several questions: Which and how many images are needed? How to deal with low-prevalence subsets? How can potential bias be detected? How should datasets be reported? What are the regulatory requirements in different countries?

We hope that these recommendations help AI developers demonstrate the utility of their products and to help regulatory agencies and end users verify reported performance measures.

Download paper

https://www.nature.com/articles/s41379-022-01147-y

Want to know more?

Lakera’s MLTest enables medical imaging companies to put reliability at the core of their engineering processes and to speed up regulatory approval. You can get started with MLTest right away, or get in touch with us at info@lakera.ai.

Lakera LLM Security Playbook
Learn how to protect against the most common LLM vulnerabilities

Download this guide to delve into the most common LLM security risks and ways to mitigate them.

GenAI Security Preparedness 

Report 2024

Get the first-of-its-kind report on how organizations are preparing for GenAI-specific threats.

Free Download
Read LLM Security Playbook

Learn about the most common LLM threats and how to prevent them.

Download

Explore AI Regulations.

Compare the EU AI Act and the White House’s AI Bill of Rights.

Understand AI Security Basics.

Get Lakera's AI Security Guide for an overview of threats and protection strategies.

Uncover LLM Vulnerabilities.

Explore real-world LLM exploits, case studies, and mitigation strategies with Lakera.

Optimize LLM Security Solutions.

Use our checklist to evaluate and select the best LLM security tools for your enterprise.

Master Prompt Injection Attacks.

Discover risks and solutions with the Lakera LLM Security Playbook.

Unlock Free AI Security Guide.

Discover risks and solutions with the Lakera LLM Security Playbook.

You might be interested
Investing in Lakera to help protect GenAI apps from malicious prompts
Investing in Lakera to help protect GenAI apps from malicious prompts
min read
•
Media Coverage

Investing in Lakera to help protect GenAI apps from malicious prompts

Investing in Lakera to help protect GenAI apps from malicious prompts

Citi Ventures invests in Lakera, the leading solution for securing AI applications at run-time.
Lakera, which protects enterprises from LLM vulnerabilities, raises $20M
Lakera, which protects enterprises from LLM vulnerabilities, raises $20M
5
min read
•
Media Coverage

Lakera, which protects enterprises from LLM vulnerabilities, raises $20M

Lakera, which protects enterprises from LLM vulnerabilities, raises $20M

Lakera, a Swiss startup that’s building technology to protect generative AI applications from malicious prompts and other threats, has raised $20 million in a Series A round led by European venture capital firm, Atomico.
Activate
untouchable mode.
Get started for free.

Lakera Guard protects your LLM applications from cybersecurity risks with a single line of code. Get started in minutes. Become stronger every day.

Join our Slack Community.

Several people are typing about AI/ML security. 
Come join us and 1000+ others in a chat that’s thoroughly SFW.